blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0888313

EP0888313 - 2,3-BENZODIAZEPINE DERIVATIVES AND THEIR USE AS AMPA-RECEPTOR INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.02.2003
Database last updated on 05.10.2024
Most recent event   Tooltip15.11.2013Lapse of the patent in a contracting statepublished on 18.12.2013  [2013/51]
Applicant(s)For all designated states
Schering Aktiengesellschaft
Müllerstrasse 170/178
13353 Berlin / DE
[N/P]
Former [1999/01]For all designated states
SCHERING AKTIENGESELLSCHAFT
Müllerstrasse 170/178
13353 Berlin / DE
Inventor(s)01 / LING, István
Almos vezér utja 44
H-1141 Budapest / HU
02 / ABRAHAM, Gizella
Haraszt u. 5
H-1118 Budapest / HU
03 / SOLYOM, Sándor
Füredi park 7
H-1144 Budapest / HU
04 / HAMORI, Tamás
Amfiteátrum ut 27
H-1031 Budapest / HU
05 / TARNAWA, István
Kerékgyárt(RTM) u. 45 c
H-1147 Budapest / HU
06 / BERZSENYI, Pál
Bulyovszky u. 12
H-1174 Budapest / HU
07 / ANDRASI, Ferenc
Kutvölgyi ut 69
H-1125 Budapest / HU
08 / CSUZDI, Emese
Lahner Gy u. 2/4
H-1046 Budapest / HU
09 / SZÖLLOSY, Márta
Kápolna u. 3
H-1105 Budapest / HU
10 / SIMAY, Antal
Pagony u. 30
H-1124 Budapest / HU
11 / PALLAGI, István
Nyirpalota ut 59
H-1157 Budapest / HU
12 / HORVATH, Katalin
Nagybányai ut 54 b
H-1025 Budapest / HU
[1999/01]
Application number, filing date97915277.429.01.1997
[1999/01]
WO1997DE00225
Priority number, dateDE199610492001.02.1996         Original published format: DE 19604920
[1999/01]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO9728135
Date:07.08.1997
Language:DE
[1997/34]
Type: A1 Application with search report 
No.:EP0888313
Date:07.01.1999
Language:DE
The application published by WIPO in one of the EPO official languages on 07.08.1997 takes the place of the publication of the European patent application.
[1999/01]
Type: B1 Patent specification 
No.:EP0888313
Date:17.04.2002
Language:DE
[2002/16]
Search report(s)International search report - published on:EP07.08.1997
ClassificationIPC:C07D243/02, A61K31/55
[1999/01]
CPC:
C07D243/02 (EP,US); A61P25/00 (EP); A61P25/16 (EP);
A61P25/28 (EP); A61P9/00 (EP); A61P9/10 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1999/01]
TitleGerman:2,3-BENZODIAZEPINDERIVATE UND DEREN VERWENDUNG ALS AMPA-REZEPTOREN-HEMMER[1999/01]
English:2,3-BENZODIAZEPINE DERIVATIVES AND THEIR USE AS AMPA-RECEPTOR INHIBITORS[1999/01]
French:DERIVES DE 2,3-BENZODIAZEPINE ET LEUR UTILISATION COMME INHIBITEURS DE RECEPTEURS D'AMPA[1999/01]
Entry into regional phase01.07.1998National basic fee paid 
01.07.1998Designation fee(s) paid 
01.07.1998Examination fee paid 
Examination procedure08.08.1997Request for preliminary examination filed
International Preliminary Examining Authority: EP
01.07.1998Examination requested  [1999/01]
08.01.1999Despatch of a communication from the examining division (Time limit: M06)
19.07.1999Reply to a communication from the examining division
30.01.2001Despatch of a communication from the examining division (Time limit: M04)
19.05.2001Reply to a communication from the examining division
09.07.2001Despatch of communication of intention to grant (Approval: Yes)
15.10.2001Communication of intention to grant the patent
25.10.2001Fee for grant paid
25.10.2001Fee for publishing/printing paid
Opposition(s)20.01.2003No opposition filed within time limit [2003/15]
Fees paidRenewal fee
18.12.1998Renewal fee patent year 03
20.12.1999Renewal fee patent year 04
19.12.2000Renewal fee patent year 05
19.12.2001Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]GB2034706  (EGYT GYOGYSZERVEGYESZETI GYAR) [Y] 1-4 * the whole document *;
 [Y]US4423044  (KOROESI JENO [HU], et al) [Y] 1-4 * column W *;
 [Y]GB2162184  (EGYT GYOGYSZERVEGYESZETI GYAR) [Y] 1-4 * the whole document *;
 [X]EP0512419  (EGYT GYOGYSZERVEGYESZETI GYAR [HU]) [X] 1,4 * siehe Seite 5, Verbindung IV *;
 [Y]  - G. DE SARRO ET AL., "GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 mice", EUROPEAN JOURNAL OF PHARMACOLOGY, AMSTERDAM NL, (1995), vol. 294, pages 411 - 22, XP002034232 [Y] 1-4 * the whole document *

DOI:   http://dx.doi.org/10.1016/0014-2999(95)00561-7
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.